These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 10469062

  • 1. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
    Fabris C, Del Forno M, Falleti E, Toniutto P, Pirisi M.
    Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
    [Abstract] [Full Text] [Related]

  • 2. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with bulimia nervosa.
    Nakai Y, Hamagaki S, Takagi R, Taniguchi A, Kurimoto F.
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):383-8. PubMed ID: 10971457
    [Abstract] [Full Text] [Related]

  • 3. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis.
    Lin SY, Wang YY, Sheu WH.
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):805-11. PubMed ID: 12460331
    [Abstract] [Full Text] [Related]

  • 4. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
    Zylberberg H, Rimaniol AC, Pol S, Masson A, De Groote D, Berthelot P, Bach JF, Bréchot C, Zavala F.
    J Hepatol; 1999 Feb; 30(2):185-91. PubMed ID: 10068094
    [Abstract] [Full Text] [Related]

  • 5. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
    Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H.
    Jpn Circ J; 1997 Aug; 61(8):657-64. PubMed ID: 9276770
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P, Tiberio M, Sivieri S, Facchinetti A, Biasi G, Gallo P.
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [Abstract] [Full Text] [Related]

  • 7. [Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis].
    Kacprzyk F.
    Pol Arch Med Wewn; 2002 Mar; 107(3):215-21. PubMed ID: 12107979
    [Abstract] [Full Text] [Related]

  • 8. Elevated serum levels of TNF-alpha, sTNF-RI and sTNF-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation.
    Haseeb MA, Shirazian DJ, Preis J.
    Cytokine; 2001 Sep 07; 15(5):266-9. PubMed ID: 11594791
    [Abstract] [Full Text] [Related]

  • 9. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
    Tsao TC, Li L, Hsieh M, Liao S, Chang KS.
    Eur Respir J; 1999 Sep 07; 14(3):490-5. PubMed ID: 10543265
    [Abstract] [Full Text] [Related]

  • 10. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
    Weiss M, Martignoni M, Petropoulou T, Sölder B, Belohradsky BH.
    Infection; 1996 Sep 07; 24(4):301-8. PubMed ID: 8875282
    [Abstract] [Full Text] [Related]

  • 11. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
    Nowak J, Rozentryt P, Szewczyk M, Gierlotka M, Duszańska A, Szyguła B, Wojnicz R, Hawranek M, Poloński L, Zembala M.
    Pol Arch Med Wewn; 2002 Mar 07; 107(3):223-9. PubMed ID: 12107980
    [Abstract] [Full Text] [Related]

  • 12. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997 Mar 07; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 13. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C, André B, Kaye O, Kaiser MJ, Bonnet V, de Groote D, Franchimont N, Malaise MG.
    Eur Cytokine Netw; 2000 Dec 07; 11(4):669-76. PubMed ID: 11125312
    [Abstract] [Full Text] [Related]

  • 14. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun 07; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 15. Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion.
    Gérain J, Liénard D, Pampallona S, Baumgartner M, Rüegg C, Buurman WA, Eggermont A, Lejeune F.
    Cytokine; 1997 Dec 07; 9(12):1034-42. PubMed ID: 9417816
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.
    Torre F, Rossol S, Pelli N, Basso M, Delfino A, Picciotto A.
    Clin Exp Immunol; 2004 Jun 07; 136(3):507-12. PubMed ID: 15147353
    [Abstract] [Full Text] [Related]

  • 17. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 07; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 18. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 07; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 19. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T.
    Invest Clin; 2001 Sep 07; 42(3):171-81. PubMed ID: 11552506
    [Abstract] [Full Text] [Related]

  • 20. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
    Havlir DV, Torriani FJ, Schrier RD, Huang JY, Lederman MM, Chervenak KA, Boom WH.
    J Clin Microbiol; 2001 Jan 07; 39(1):298-303. PubMed ID: 11136787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.